Mumbai-based startup Patanjali Pharma has developed a Rapid Antigen Test that offers Covid-19 diagnosis and surveillance at the cost of ₹100 per test. The test will complement the gold standard RT PCR
DST supported startup develops affordable test kits for early diagnosis of Covid-19 in rural & resource constraint areas
A Mumbai-based startup is ready with its affordable
Rapid Antigen Test that offers
COVID 19 diagnosis & surveillance at the cost of Rs 100 per test.
The test developed by
Patanjali Pharma will complement the gold standard RTPCR & Rapid antigen tests and make it one of the most affordable ones available in the market.
The Centre for Augmenting WAR with COVID-19 Health Crisis (CAWACH), an initiative by the
Department of Science and Technology (
DST), supported the startup in July, 2020 to develop Rapid Covid 19 diagnostics (both Rapid antibody and antigen tests for surveillance and early diagnosis of Covid- 19, respectively).